Developmental and hormonal signals dramatically alter the localization and abundance of insulin receptor substrate proteins in the mammary gland.
Insulin receptor substrates (IRS) are central integrators of hormone, cytokine, and growth factor signaling. IRS proteins can be phosphorylated by a number of signaling pathways critical to normal mammary gland development. Studies in transgenic mice that overexpress IGF-I in the mammary gland suggested that IRS expression is important in the regulation of normal postlactational mammary involution. The goal of these studies was to examine IRS expression in the mouse mammary gland and determine the importance of IRS-1 to mammary development in the virgin mouse. IRS-1 and -2 show distinct patterns of protein expression in the virgin mouse mammary gland, and protein abundance is dramatically increased during pregnancy and lactation, but rapidly lost during involution. Consistent with hormone regulation, IRS-1 protein levels are reduced by ovariectomy, induced by combined treatment with estrogen and progesterone, and vary considerably throughout the estrous cycle. These changes occur without similar changes in mRNA levels, suggesting posttranscriptional control. Mammary glands from IRS-1 null mice have smaller fat pads than wild-type controls, but this reduction is proportional to the overall reduction in body size. Development of the mammary duct (terminal endbuds and branch points) is not altered by the loss of IRS-1, and pregnancy-induced proliferation is not changed. These data indicate that IRS undergo complex developmental and hormonal regulation in the mammary gland, and that IRS-1 is more likely to regulate mammary function in lactating mice than in virgin or pregnant mice.
Lee
A V
AV
The Breast Center, Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA. avlee@breastcenter.tmc.edu
Zhang
P
P
Ivanova
M
M
Bonnette
S
S
Oesterreich
S
S
Rosen
J M
JM
Grimm
S
S
Hovey
R C
RC
Vonderhaar
B K
BK
Kahn
C R
CR
Torres
D
D
George
J
J
Mohsin
S
S
Allred
D C
DC
Hadsell
D L
DL
D000273:Adipose Tissue / Q000737:chemistry / Q000254:growth & development / Q000502:physiology; D000818:Animals; D004967:Estrogens / Q000494:pharmacology*; D030762:Estrous Cycle / Q000502:physiology; D005260:Female; D015870:Gene Expression / Q000187:drug effects / Q000502:physiology; D055504:Insulin Receptor Substrate Proteins; D047908:Intracellular Signaling Peptides and Proteins; D008321:Mammary Glands, Animal / Q000737:chemistry / Q000254:growth & development / Q000502:physiology*; D051379:Mice; D008815:Mice, Inbred Strains; D010052:Ovariectomy; D010750:Phosphoproteins / Q000032:analysis / Q000235:genetics*; D011247:Pregnancy; D011374:Progesterone / Q000494:pharmacology*; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology*
D004967:Estrogens; D055504:Insulin Receptor Substrate Proteins; D047908:Intracellular Signaling Peptides and Proteins; C526295:Irs1 protein, mouse; C526298:Irs2 protein, mouse; D010750:Phosphoproteins; D011374:Progesterone